TRIM21 and viral infectious disease: Specifically, nucleoprotein-specific NNAbs, commonly induced upon infection of enveloped viruses, have been demonstrated to confer protection via the TRIM21 pathway in many viral infections: lymphocytic choriomeningitis virus, adenoviruses, influenza virus, and paramyxoviruses (30, 31).